Alzheimer’s – cannabis treatment

According to the 2018 World Alzheimer’s Report, 50 million people have dementia globally, and in Canada alone, the number stands at over 560,000.

Alzheimer’s is the most common form of dementia, comprising about 2/3 of all dementia diagnoses. While there are no known cures or disease-modifying therapies, there are interventions to manage a variety of Neuropsychiatric symptoms (NPS) that are common to dementia.

Given the limited therapeutic options and inconsistent evidence base, there is a need for alternative therapies in the growing population of dementia patients. Medical cannabis has been highlighted as one of the potential alternative treatments for dementia.

Heeyl’s network of physicians have years of experience guiding medicinal cannabis users, including individuals diagnosed with Alzheimer’s and dementia.

During your first consultation, we will directly address your questions and concerns and provide personalized guidance and recommendations.

Consultations are confidential and unbiased; schedule your first consult today.